KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Interest Coverage Ratio (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2.58%
Dec 31, 2025 12.96%
Sep 30, 2025 -3.65%
Jun 30, 2025 134.89%
Mar 31, 2025 -47.33%
Dec 31, 2024 17.28%
Sep 30, 2024 11.65%
Jun 30, 2024 96.45%
Mar 31, 2024 -22.31%
Dec 31, 2023 -41.86%
Sep 30, 2023 -25.40%
Jun 30, 2023 0.89%
Mar 31, 2023 -34.16%
Dec 31, 2022 -25.66%
Sep 30, 2022 8.96%
Jun 30, 2022 -21.72%
Mar 31, 2022 23.22%
Dec 31, 2021 -14.39%
Sep 30, 2021 172.64%
Jun 30, 2021 -60.55%
Mar 31, 2021 18.30%
Dec 31, 2020 -22.26%
Sep 30, 2020 3.50%
Jun 30, 2020 15.30%
Mar 31, 2020 0.03%
Dec 31, 2019 -13.99%
Sep 30, 2019 -1.93%
Jun 30, 2019 11.92%
Mar 31, 2019 6.50%
Dec 31, 2018 3.41%
Sep 30, 2018 -19.82%
Jun 30, 2018 1.19%
Mar 31, 2018 19.27%
Dec 31, 2017 -9.89%
Sep 30, 2017 -10.71%
Jun 30, 2017 5.75%
Mar 31, 2017 4.91%
Dec 31, 2016 -2.56%
Sep 30, 2016 2.26%
Jun 30, 2016 -6.93%
Mar 31, 2016 16.14%
Dec 31, 2015 -15.19%
Sep 30, 2015 10.67%
Jun 30, 2015 -6.60%
Mar 31, 2015 43.54%
Dec 31, 2014 2.57%
Sep 30, 2014 -19.20%
Jun 30, 2014 28.07%
Mar 31, 2014 15.80%
Dec 31, 2013 -30.76%
Sep 30, 2013 2.12%
Jun 30, 2013 17.30%
Mar 31, 2013 46.65%
Dec 31, 2012 -28.80%
Sep 30, 2012 -15.40%
Jun 30, 2012 -1.24%
Mar 31, 2012 5.47%
Dec 31, 2011 79.34%
Sep 30, 2011 -69.57%
Jun 30, 2011 13.99%
Mar 31, 2011 45.28%
Dec 31, 2010 -33.14%
Sep 30, 2010 -4.45%
Jun 30, 2010 1.04%
Mar 31, 2010 29.15%
Dec 31, 2009 -31.51%
Sep 30, 2009 18.88%
Jun 30, 2009 8.09%